Wright Medical settles $139.56 million exchange convertibles due 2023

By Marisa Wong

Morgantown, W.Va., Feb. 8 – Wright Medical Group NV’s wholly owned subsidiary, Wright Medical Group, Inc., issued $139,556,000 of additional 1.625% cash convertible senior notes due 2023 on Thursday, according to an 8-K filing with the Securities and Exchange Commission.

The additional notes were delivered upon settlement of previously announced privately negotiated exchange agreements. Wright had offered to exchange existing 2% cash convertible senior notes due 2020 for new 2023 notes.

Holders exchanged a total of $130,134,000 of the existing 2020 notes for the additional 2023 notes.

The company had previously announced that it would exchange $112,106,000 of the 2020 notes for $120,223,000 of 2023 notes, as reported.

Following the exchange, the total principal amount of the 2023 notes is $814,556,000, which includes the original $675 million issued in June 2018, and the total amount of 2020 notes outstanding is $56.5 million, according to the 8-K filing.

Wright Medical Group is an Amsterdam-based global medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.